73150-150-06 : NDC 2026 Code

73150-150-06 : Ublituximab ( Briumvi )

Additionally :

You can get information about “73150-150-06” NDC code in 73150-150-06 in HTML format

HTML | 73150-150-06 in TXT (Plain Text) format

TXT | 73150-150-06 in PDF (Portable Document Format)

PDF | 73150-150-06 in XML format

XML formats.

NDC Code : 73150-150-06 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "73150-150-06",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06)  / 6 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "73150-0150-06",
    "ProductNDC": "73150-150",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Briumvi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ublituximab",
    "DosageFormName": "INJECTION, SOLUTION, CONCENTRATE",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20221228",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761238",
    "LabelerName": "TG Therapeutics, Inc.",
    "SubstanceName": "UBLITUXIMAB",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/6mL",
    "Pharm_Classes": "CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-09-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20221228",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}